Skip to content

Clinical trials

Hypersensitivity trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Country / region: Italy Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20081
20091
20101
20111
20125
20131
20143
20151
20161
20174
20187
20191
20202
20213
20223
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Unknown status7
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federico II University7
Aimmune Therapeutics, Inc.4
AstraZeneca2
Azienda USL Reggio Emilia - IRCCS2
Celgene2
Cogent Biosciences, Inc.2
Novartis Pharmaceuticals2
Pfizer2
University of Campania Luigi Vanvitelli2
University of Genova2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity43
Immune System Diseases5
Hypersensitivity, Immediate4
Peanut Hypersensitivity4
Asthma3
Eczema3
Neoplasms3
Skin Diseases3
Dermatitis2
Dermatitis, Atopic2

Trials

Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.